Home > Publications database > CP-GEP Identifies High-Risk T1a Melanoma Patients Beyond Established Adverse Features. > print

001     305399
005     20251017115451.0
024 7 _ |a 10.1016/j.jaad.2025.10.036
|2 doi
024 7 _ |a pmid:41093058
|2 pmid
024 7 _ |a 0190-9622
|2 ISSN
024 7 _ |a 1097-6787
|2 ISSN
037 _ _ |a DKFZ-2025-02136
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Yu, Wesley Y
|b 0
245 _ _ |a CP-GEP Identifies High-Risk T1a Melanoma Patients Beyond Established Adverse Features.
260 _ _ |a Amsterdam [u.a.]
|c 2025
|b Elsevier
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1760623100_219522
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a epub
536 _ _ |a 311 - Zellbiologie und Tumorbiologie (POF4-311)
|0 G:(DE-HGF)POF4-311
|c POF4-311
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a CP-GEP
|2 Other
650 _ 7 |a Merlin Assay
|2 Other
650 _ 7 |a melanoma
|2 Other
650 _ 7 |a metastasis
|2 Other
650 _ 7 |a risk prediction
|2 Other
650 _ 7 |a sentinel lymph node biopsy
|2 Other
700 1 _ |a Pazhava, Ani
|b 1
700 1 _ |a Weitemeyer, Marie B
|b 2
700 1 _ |a Hölmich, Lisbet R
|b 3
700 1 _ |a Johansson, Iva
|b 4
700 1 _ |a Bagge, Roger Olofsson
|b 5
700 1 _ |a Utikal, Jochen
|0 P:(DE-He78)a229f7724466e7efadf4a1ace1ff8af3
|b 6
|u dkfz
700 1 _ |a Venna, Suraj
|b 7
700 1 _ |a Jackson, Julie
|b 8
700 1 _ |a Amaral, Teresa
|b 9
700 1 _ |a van Akkooi, Alexander
|b 10
700 1 _ |a Kolodney, Michael S
|b 11
700 1 _ |a McArthur, Grant A
|b 12
700 1 _ |a Meves, Alexander
|b 13
773 _ _ |a 10.1016/j.jaad.2025.10.036
|g p. S019096222503004X
|0 PERI:(DE-600)2001404-1
|p nn
|t Journal of the American Academy of Dermatology
|v nn
|y 2025
|x 0190-9622
909 C O |o oai:inrepo02.dkfz.de:305399
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-He78)a229f7724466e7efadf4a1ace1ff8af3
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-311
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Zellbiologie und Tumorbiologie
|x 0
914 1 _ |y 2025
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2024-12-27
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J AM ACAD DERMATOL : 2022
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2024-12-27
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-27
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b J AM ACAD DERMATOL : 2022
|d 2024-12-27
920 1 _ |0 I:(DE-He78)A370-20160331
|k A370
|l KKE Dermatoonkologie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)A370-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21